Communication Equipment
Compare Stocks
4 / 10Stock Comparison
LTRX vs SIFY vs CSCO vs HCTI
Revenue, margins, valuation, and 5-year total return — side by side.
Telecommunications Services
Communication Equipment
Medical - Healthcare Information Services
LTRX vs SIFY vs CSCO vs HCTI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Communication Equipment | Telecommunications Services | Communication Equipment | Medical - Healthcare Information Services |
| Market Cap | $231M | $1.15B | $364.95B | $49K |
| Revenue (TTM) | $119M | $41.45B | $59.05B | $13M |
| Net Income (TTM) | $-7M | $-1.50B | $11.08B | $-6M |
| Gross Margin | 42.9% | 34.2% | 64.4% | 13.1% |
| Operating Margin | -5.4% | 5.2% | 23.0% | -45.2% |
| Forward P/E | 34.8x | — | 22.2x | — |
| Total Debt | $21M | $39.51B | $29.64B | $3M |
| Cash & Equiv. | $20M | $5.00B | $9.47B | $20K |
LTRX vs SIFY vs CSCO vs HCTI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 21 | May 26 | Return |
|---|---|---|---|
| Lantronix, Inc. (LTRX) | 100 | 60.1 | -39.9% |
| Sify Technologies L… (SIFY) | 100 | 74.3 | -25.7% |
| Cisco Systems, Inc. (CSCO) | 100 | 164.7 | +64.7% |
| Healthcare Triangle… (HCTI) | 100 | 0.0 | -100.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: LTRX vs SIFY vs CSCO vs HCTI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
LTRX is the clearest fit if your priority is long-term compounding.
- 425.2% 10Y total return vs CSCO's 301.7%
SIFY is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 11.9%, EPS growth -8.8%, 3Y rev CAGR 13.9%
- 11.9% revenue growth vs HCTI's -64.8%
- +264.2% vs HCTI's -99.9%
CSCO carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 15 yrs, beta 0.92, yield 1.7%
- Lower volatility, beta 0.92, Low D/E 63.3%, current ratio 1.00x
- Beta 0.92, yield 1.7%, current ratio 1.00x
- Better valuation composite
HCTI lags the leaders in this set but could rank higher in a more targeted comparison.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.9% revenue growth vs HCTI's -64.8% | |
| Value | Better valuation composite | |
| Quality / Margins | 18.8% margin vs HCTI's -48.9% | |
| Stability / Safety | Beta 0.92 vs HCTI's 3.07 | |
| Dividends | 1.7% yield, 15-year raise streak, vs SIFY's 0.0%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +264.2% vs HCTI's -99.9% | |
| Efficiency (ROA) | 9.0% ROA vs HCTI's -60.0%, ROIC 13.0% vs -6.3% |
LTRX vs SIFY vs CSCO vs HCTI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
LTRX vs SIFY vs CSCO vs HCTI — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CSCO leads in 4 of 6 categories
SIFY leads 1 • LTRX leads 0 • HCTI leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CSCO leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CSCO is the larger business by revenue, generating $59.1B annually — 4563.3x HCTI's $13M. CSCO is the more profitable business, keeping 18.8% of every revenue dollar as net income compared to HCTI's -48.9%. On growth, HCTI holds the edge at +44.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $119M | $41.4B | $59.1B | $13M |
| EBITDAEarnings before interest/tax | -$2M | $8.1B | $16.1B | -$6M |
| Net IncomeAfter-tax profit | -$7M | -$1.5B | $11.1B | -$6M |
| Free Cash FlowCash after capex | $8M | $0 | $12.8B | -$12M |
| Gross MarginGross profit ÷ Revenue | +42.9% | +34.2% | +64.4% | +13.1% |
| Operating MarginEBIT ÷ Revenue | -5.4% | +5.2% | +23.0% | -45.2% |
| Net MarginNet income ÷ Revenue | -5.5% | -3.6% | +18.8% | -48.9% |
| FCF MarginFCF ÷ Revenue | +7.1% | -9.2% | +21.8% | -94.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +5.9% | +2.5% | +9.7% | +44.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +69.9% | -3.7% | +29.5% | -63.8% |
Valuation Metrics
Evenly matched — SIFY and CSCO each lead in 2 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, SIFY's 18.2x EV/EBITDA is more attractive than CSCO's 26.3x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $231M | $1.1B | $365.0B | $49,177 |
| Enterprise ValueMkt cap + debt − cash | $232M | $1.5B | $385.1B | $3M |
| Trailing P/EPrice ÷ TTM EPS | -20.10x | -119.57x | 36.14x | -0.01x |
| Forward P/EPrice ÷ next-FY EPS est. | 34.81x | — | 22.18x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 18.19x | 26.34x | — |
| Price / SalesMarket cap ÷ Revenue | 1.88x | 2.73x | 6.44x | 0.00x |
| Price / BookPrice ÷ Book value/share | 3.03x | 4.65x | 7.87x | — |
| Price / FCFMarket cap ÷ FCF | 34.13x | — | 27.46x | — |
Profitability & Efficiency
CSCO leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
CSCO delivers a 23.2% return on equity — every $100 of shareholder capital generates $23 in annual profit, vs $-113 for HCTI. LTRX carries lower financial leverage with a 0.28x debt-to-equity ratio, signaling a more conservative balance sheet compared to SIFY's 1.96x. On the Piotroski fundamental quality scale (0–9), CSCO scores 8/9 vs HCTI's 3/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -8.8% | -7.7% | +23.2% | -112.9% |
| ROA (TTM)Return on assets | -5.4% | -1.8% | +9.0% | -60.0% |
| ROICReturn on invested capital | -10.5% | +3.3% | +13.0% | -6.3% |
| ROCEReturn on capital employed | -11.0% | +4.4% | +13.7% | — |
| Piotroski ScoreFundamental quality 0–9 | 4 | 3 | 8 | 3 |
| Debt / EquityFinancial leverage | 0.28x | 1.96x | 0.63x | — |
| Net DebtTotal debt minus cash | $1M | $34.5B | $20.2B | $3M |
| Cash & Equiv.Liquid assets | $20M | $5.0B | $9.5B | $20,000 |
| Total DebtShort + long-term debt | $21M | $39.5B | $29.6B | $3M |
| Interest CoverageEBIT ÷ Interest expense | -48.12x | 0.82x | 9.64x | -3.79x |
Total Returns (Dividends Reinvested)
SIFY leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CSCO five years ago would be worth $18,718 today (with dividends reinvested), compared to $0 for HCTI. Over the past 12 months, SIFY leads with a +264.2% total return vs HCTI's -99.9%. The 3-year compound annual growth rate (CAGR) favors SIFY at 28.8% vs HCTI's -96.0% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -5.2% | +29.2% | +22.3% | -93.7% |
| 1-Year ReturnPast 12 months | +173.7% | +264.2% | +57.5% | -99.9% |
| 3-Year ReturnCumulative with dividends | +59.7% | +113.4% | +109.3% | -100.0% |
| 5-Year ReturnCumulative with dividends | +8.8% | -12.1% | +87.2% | -100.0% |
| 10-Year ReturnCumulative with dividends | +425.2% | +141.0% | +301.7% | -100.0% |
| CAGR (3Y)Annualised 3-year return | +16.9% | +28.8% | +27.9% | -96.0% |
Risk & Volatility
CSCO leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CSCO is the less volatile stock with a 0.92 beta — it tends to amplify market swings less than HCTI's 3.07 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CSCO currently trades 97.3% from its 52-week high vs HCTI's 0.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.17x | 1.33x | 0.92x | 3.07x |
| 52-Week HighHighest price in past year | $8.24 | $17.85 | $94.72 | $7410.00 |
| 52-Week LowLowest price in past year | $2.03 | $4.15 | $59.07 | $0.29 |
| % of 52W HighCurrent price vs 52-week peak | +70.8% | +89.0% | +97.3% | +0.0% |
| RSI (14)Momentum oscillator 0–100 | 59.1 | 56.7 | 63.9 | 36.7 |
| Avg Volume (50D)Average daily shares traded | 613K | 56K | 18.9M | 572K |
Analyst Outlook
CSCO leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: LTRX as "Buy", SIFY as "Buy", CSCO as "Buy". Consensus price targets imply 51.5% upside for LTRX (target: $9) vs 4.7% for CSCO (target: $97). CSCO is the only dividend payer here at 1.75% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | — |
| Price TargetConsensus 12-month target | $8.83 | — | $96.50 | — |
| # AnalystsCovering analysts | 6 | 1 | 73 | — |
| Dividend YieldAnnual dividend ÷ price | — | +0.0% | +1.7% | — |
| Dividend StreakConsecutive years of raises | — | 0 | 15 | — |
| Dividend / ShareAnnual DPS | — | $0.36 | $1.61 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +2.0% | 0.0% |
CSCO leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SIFY leads in 1 (Total Returns). 1 tied.
LTRX vs SIFY vs CSCO vs HCTI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is LTRX or SIFY or CSCO or HCTI a better buy right now?
For growth investors, Sify Technologies Limited (SIFY) is the stronger pick with 11.
9% revenue growth year-over-year, versus -64. 8% for Healthcare Triangle, Inc. (HCTI). Cisco Systems, Inc. (CSCO) offers the better valuation at 36. 1x trailing P/E (22. 2x forward), making it the more compelling value choice. Analysts rate Lantronix, Inc. (LTRX) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — LTRX or SIFY or CSCO or HCTI?
On forward P/E, Cisco Systems, Inc.
is actually cheaper at 22. 2x.
03Which is the better long-term investment — LTRX or SIFY or CSCO or HCTI?
Over the past 5 years, Cisco Systems, Inc.
(CSCO) delivered a total return of +87. 2%, compared to -100. 0% for Healthcare Triangle, Inc. (HCTI). Over 10 years, the gap is even starker: LTRX returned +425. 2% versus HCTI's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — LTRX or SIFY or CSCO or HCTI?
By beta (market sensitivity over 5 years), Cisco Systems, Inc.
(CSCO) is the lower-risk stock at 0. 92β versus Healthcare Triangle, Inc. 's 3. 07β — meaning HCTI is approximately 234% more volatile than CSCO relative to the S&P 500. On balance sheet safety, Lantronix, Inc. (LTRX) carries a lower debt/equity ratio of 28% versus 196% for Sify Technologies Limited — giving it more financial flexibility in a downturn.
05Which is growing faster — LTRX or SIFY or CSCO or HCTI?
By revenue growth (latest reported year), Sify Technologies Limited (SIFY) is pulling ahead at 11.
9% versus -64. 8% for Healthcare Triangle, Inc. (HCTI). On earnings-per-share growth, the picture is similar: Healthcare Triangle, Inc. grew EPS 45. 6% year-over-year, compared to -877. 8% for Sify Technologies Limited. Over a 3-year CAGR, SIFY leads at 13. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — LTRX or SIFY or CSCO or HCTI?
Cisco Systems, Inc.
(CSCO) is the more profitable company, earning 18. 0% net margin versus -51. 0% for Healthcare Triangle, Inc. — meaning it keeps 18. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CSCO leads at 20. 8% versus -40. 6% for HCTI. At the gross margin level — before operating expenses — CSCO leads at 64. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is LTRX or SIFY or CSCO or HCTI more undervalued right now?
On forward earnings alone, Cisco Systems, Inc.
(CSCO) trades at 22. 2x forward P/E versus 34. 8x for Lantronix, Inc. — 12. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for LTRX: 51. 5% to $8. 83.
08Which pays a better dividend — LTRX or SIFY or CSCO or HCTI?
In this comparison, CSCO (1.
7% yield) pays a dividend. LTRX, SIFY, HCTI do not pay a meaningful dividend and should not be held primarily for income.
09Is LTRX or SIFY or CSCO or HCTI better for a retirement portfolio?
For long-horizon retirement investors, Cisco Systems, Inc.
(CSCO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 92), 1. 7% yield, +301. 7% 10Y return). Healthcare Triangle, Inc. (HCTI) carries a higher beta of 3. 07 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CSCO: +301. 7%, HCTI: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between LTRX and SIFY and CSCO and HCTI?
These companies operate in different sectors (LTRX (Technology) and SIFY (Communication Services) and CSCO (Technology) and HCTI (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
CSCO pays a dividend while LTRX, SIFY, HCTI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.